Cartesian Therapeutics
RNAC
RNAC
102 hedge funds and large institutions have $71.9M invested in Cartesian Therapeutics in 2022 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 28 increasing their positions, 41 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less funds holding
Funds holding: →
24% less first-time investments, than exits
New positions opened: 13 | Existing positions closed: 17
32% less repeat investments, than reductions
Existing positions increased: 28 | Existing positions reduced: 41
61% less capital invested
Capital invested by funds: $186M → $71.9M (-$114M)
Holders
102
Holding in Top 10
1
Calls
$188K
Puts
$45K
Top Buyers
| 1 | +$1.63M | |
| 2 | +$1.25M | |
| 3 | +$1.09M | |
| 4 |
EAM
Erste Asset Management
Vienna,
Austria
|
+$1.01M |
| 5 |
Millennium Management
New York
|
+$968K |
Top Sellers
| 1 | -$1.82M | |
| 2 | -$804K | |
| 3 | -$587K | |
| 4 |
Morgan Stanley
New York
|
-$569K |
| 5 |
CAM
ClariVest Asset Management
San Diego,
California
|
-$539K |